German
|
English
|
French
Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "L03AX" (12)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Other Immunostimulants (L03AX) 1 products
WHO-DDD
CI
Synerga
100 ml
k.A.
Solution (oral): Escherichiae coli Lysatum (Stamm Laves)
Laves-Arzneimittel
Gesellschaft mit
beschränkter Haftung,
Ronnenberg,
Zweigniederlassung
Schötz
D
FB
G
Bcg Vaccine (L03AX03) 3 products
WHO-DDD
DrugBank.ca
L
IP
CI
BCG-medac
130.32
158.15
10 %
Pulver und Lösungsmittel zur Herstellung einer Suspension zur intravesikalen Anwendung: Bacillus Calmette-Guérin (Bcg) Vivus Attenuatum (Rivm) 0.2-3
Labatec Pharma SA
A / SL
FB
G
IP
OncoTICE
Durchstechflasche(n)
97.53
122.50
10 %
Pulver zur Herstellung einer Suspension zur intravesikalen Anwendung: Bacillus Calmette-Guérin (Bcg) Vivus Attenuatum (Tice) 200-800
MSD Merck Sharp &
Dohme AG
●
A / SL
FB
G
IP
CI
BCG-medac
k.A.
Pulver und Lösungsmittel zur Herstellung einer Suspension zur intravesikalen Anwendung: Bacillus Calmette-Guérin (Bcg) Vivus Attenuatum (Rivm) 0.2-3
Labatec Pharma SA
A
FB
G
Tasonermin (L03AX11) 1 products
WHO-DDD
IP
Beromun
4
k.A.
Lyophilisate: Tasonerminum 1 mg
Eumedica
Pharmaceuticals AG
A
FB
G
Glatiramer Acetate (L03AX13) 6 products
WHO-DDD
IP
CI
Copaxone 20mg/ml
28 Fertigspritze(n)
778.94
855.90
10 %
Injection solution in prefilled syringe: Glatirameri Acetas 20 mg/ml
Teva Pharma AG
B / SL / SO
FB
G
L
IP
CI
Copaxone 40mg/ml
12
737.70
805.10
10 %
Injection solution in prefilled syringe: Glatirameri Acetas 40 mg/ml
Teva Pharma AG
B / SL / SO
FB
G
IP
CI
Glatiramyl 20 mg/ml
28
654.31
728.00
10 %
Injection solution in prefilled syringe: Glatirameri Acetas 20 mg/ml
Viatris Pharma GmbH
B / SL / SG
FB
G
L
IP
CI
Glatiramyl 40 mg/ml
12
516.39
578.00
10 %
Injection solution in prefilled syringe: Glatirameri Acetas 40 mg/ml
Viatris Pharma GmbH
B / SL / SG
FB
G
L
IP
CI
Copaxone Pen 40 mg/ml
12
737.70
805.10
10 %
Injektionslösung im Fertigpen: Glatirameri Acetas 40 mg/ml
Teva Pharma AG
B / SL
FB
G
IP
CI
Copaxone Pen 40 mg/ml
3
k.A.
Injektionslösung im Fertigpen: Glatirameri Acetas 40 mg/ml
Teva Pharma AG
B
FB
G
Plerixafor (L03AX16) 1 products
WHO-DDD
DrugBank.ca
IP
PP
Mozobil 20mg/mL
Durchstechflasche(n) à 1.2 ml
k.A.
Injection solution: Plerixaforum 20 mg/ml
Sanofi-Aventis
(Suisse) SA
A
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home
